FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890936859> ?p ?o ?g. }

• W2890936859 abstract "Background Current guidelines recommend sacubitril/valsartan for patients with heart failure with reduced ejection fraction, but the rate of adoption in the United States has been slow. Methods and Results Using data from CHAMP-HF (Change the Management of Patients With Heart Failure), we described current sacubitril/valsartan use and identified patient, provider, and practice characteristics associated with its use. We considered patients to be on sacubitril/valsartan if they were prescribed it before enrollment or initiated on it at the baseline visit. We excluded patients with a contraindication to sacubitril/valsartan and practices with <10 patients enrolled. Of 4216 patients from 121 sites, 616 (15%) were prescribed sacubitril/valsartan, 2506 (59%) an angiotensin-converting enzyme (ACE) inhibitor/angiotensin receptor blocker (ARB), and 1094 (26%) neither. Patients prescribed sacubitril/valsartan were younger (63 years versus 66 years ACE inhibitor/ARB versus 69 years neither, P <0.001), less likely to have chronic kidney disease (15% versus 17% ACE inhibitor/ARB versus 30% neither, P <0.001), more likely to have cardiac resynchronization therapy (12% versus 7% ACE inhibitor/ARB versus 7% neither, P <0.001), and had lower ejection fraction (27% versus 30% ACE inhibitor/ARB versus 30% neither, P <0.001). Larger practices, based on number of cardiologists and advanced practice providers, were associated with the highest sacubitril/valsartan use. After multivariable adjustment, the number of advanced practice providers was associated with sacubitril/valsartan use (adjusted odds ratio,1.08; 95% CI, 1.03–1.14). Conclusions Despite current guideline recommendations, adoption of sacubitril/valsartan remains low. Provider and practice characteristics associated with sacubitril/valsartan use were related to general practice size and were not associated with practice characteristics specific for heart failure. Further research is needed to identify strategies for effective quality improvement interventions in chronic heart failure with reduced ejection fraction." @default.
• W2890936859 created "2018-09-27" @default.
• W2890936859 creator A5003147572 @default.
• W2890936859 creator A5012849300 @default.
• W2890936859 creator A5015021993 @default.
• W2890936859 creator A5018839160 @default.
• W2890936859 creator A5022314919 @default.
• W2890936859 creator A5043643766 @default.
• W2890936859 creator A5063965210 @default.
• W2890936859 creator A5064343127 @default.
• W2890936859 creator A5065883685 @default.
• W2890936859 creator A5070928171 @default.
• W2890936859 creator A5074474897 @default.
• W2890936859 creator A5075249427 @default.
• W2890936859 creator A5080475090 @default.
• W2890936859 date "2018-09-01" @default.
• W2890936859 modified "2023-10-16" @default.
• W2890936859 title "Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States" @default.
• W2890936859 cites W2058056848 @default.
• W2890936859 cites W2103873084 @default.
• W2890936859 cites W2113698123 @default.
• W2890936859 cites W2315712189 @default.
• W2890936859 cites W2468095632 @default.
• W2890936859 cites W2601058970 @default.
• W2890936859 cites W2608132149 @default.
• W2890936859 cites W2765138321 @default.
• W2890936859 cites W2786847451 @default.
• W2890936859 cites W2794297420 @default.
• W2890936859 cites W2807760375 @default.
• W2890936859 cites W2883756867 @default.
• W2890936859 cites W4238907867 @default.
• W2890936859 doi "https://doi.org/10.1161/circheartfailure.118.005400" @default.
• W2890936859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30354360" @default.
• W2890936859 hasPublicationYear "2018" @default.
• W2890936859 type Work @default.
• W2890936859 sameAs 2890936859 @default.
• W2890936859 citedByCount "35" @default.
• W2890936859 countsByYear W28909368592019 @default.
• W2890936859 countsByYear W28909368592020 @default.
• W2890936859 countsByYear W28909368592021 @default.
• W2890936859 countsByYear W28909368592022 @default.
• W2890936859 countsByYear W28909368592023 @default.
• W2890936859 crossrefType "journal-article" @default.
• W2890936859 hasAuthorship W2890936859A5003147572 @default.
• W2890936859 hasAuthorship W2890936859A5012849300 @default.
• W2890936859 hasAuthorship W2890936859A5015021993 @default.
• W2890936859 hasAuthorship W2890936859A5018839160 @default.
• W2890936859 hasAuthorship W2890936859A5022314919 @default.
• W2890936859 hasAuthorship W2890936859A5043643766 @default.
• W2890936859 hasAuthorship W2890936859A5063965210 @default.
• W2890936859 hasAuthorship W2890936859A5064343127 @default.
• W2890936859 hasAuthorship W2890936859A5065883685 @default.
• W2890936859 hasAuthorship W2890936859A5070928171 @default.
• W2890936859 hasAuthorship W2890936859A5074474897 @default.
• W2890936859 hasAuthorship W2890936859A5075249427 @default.
• W2890936859 hasAuthorship W2890936859A5080475090 @default.
• W2890936859 hasBestOaLocation W28909368591 @default.
• W2890936859 hasConcept C104849204 @default.
• W2890936859 hasConcept C126322002 @default.
• W2890936859 hasConcept C142724271 @default.
• W2890936859 hasConcept C164705383 @default.
• W2890936859 hasConcept C204787440 @default.
• W2890936859 hasConcept C27016395 @default.
• W2890936859 hasConcept C2775999527 @default.
• W2890936859 hasConcept C2776494729 @default.
• W2890936859 hasConcept C2776754050 @default.
• W2890936859 hasConcept C2777387769 @default.
• W2890936859 hasConcept C2778198053 @default.
• W2890936859 hasConcept C2779611605 @default.
• W2890936859 hasConcept C2908929049 @default.
• W2890936859 hasConcept C71924100 @default.
• W2890936859 hasConcept C78085059 @default.
• W2890936859 hasConcept C84393581 @default.
• W2890936859 hasConceptScore W2890936859C104849204 @default.
• W2890936859 hasConceptScore W2890936859C126322002 @default.
• W2890936859 hasConceptScore W2890936859C142724271 @default.
• W2890936859 hasConceptScore W2890936859C164705383 @default.
• W2890936859 hasConceptScore W2890936859C204787440 @default.
• W2890936859 hasConceptScore W2890936859C27016395 @default.
• W2890936859 hasConceptScore W2890936859C2775999527 @default.
• W2890936859 hasConceptScore W2890936859C2776494729 @default.
• W2890936859 hasConceptScore W2890936859C2776754050 @default.
• W2890936859 hasConceptScore W2890936859C2777387769 @default.
• W2890936859 hasConceptScore W2890936859C2778198053 @default.
• W2890936859 hasConceptScore W2890936859C2779611605 @default.
• W2890936859 hasConceptScore W2890936859C2908929049 @default.
• W2890936859 hasConceptScore W2890936859C71924100 @default.
• W2890936859 hasConceptScore W2890936859C78085059 @default.
• W2890936859 hasConceptScore W2890936859C84393581 @default.
• W2890936859 hasIssue "9" @default.
• W2890936859 hasLocation W28909368591 @default.
• W2890936859 hasOpenAccess W2890936859 @default.
• W2890936859 hasPrimaryLocation W28909368591 @default.
• W2890936859 hasRelatedWork W2758753471 @default.
• W2890936859 hasRelatedWork W2776335933 @default.
• W2890936859 hasRelatedWork W2904992990 @default.
• W2890936859 hasRelatedWork W2914028752 @default.
• W2890936859 hasRelatedWork W2969131214 @default.
• W2890936859 hasRelatedWork W3188325112 @default.
• W2890936859 hasRelatedWork W3195938057 @default.

• next